Stem Cell Market By Product, Therapy and Application - Global Industry Analysis And Forecast To 2027
Published On : April 2019 Pages : 144 Category: Biotechnology Report Code : HC043337
Stem Cell Market By Product (Very Small Embryonic Like Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells and Human Embryonic Stem Cells), Therapy (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy) and Application (Drug Discovery & Development and Regenerative Medicine) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The stem cell is the cell that has the extraordinary capability of developing into specific types of cell in the body. Later on these cells may be utilized for replacing tissues and cells that are been lost or damaged because of ailment. These cell possesses the properties like production of new cells by continuous division and changing to other types of cells for making up the human body. Therefore, the Stem Cell Market is anticipated to expand and has tremendous scope during the forecast period. The global Stem Cell Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
By Product the market is segmented into Very Small Embryonic Like Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells and Human Embryonic Stem Cells. The Adult Stem Cells section is leading the market due to lesser contamination linked with the sub-culturing, human body compatibility, etc.
By Therapy the market is segmented into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. The Autologous Stem Cell Therapy section is leading the market due to more utilization of these products due to the high compatibility, various companies involved in the development of this therapy, etc.
By Application the market is segmented into Drug Discovery & Development and Regenerative Medicine. The Regenerative Medicine section is leading the market due to initial intervention for the treatments to cure the traumatic injury & degenerative diseases and some other factors.
Regional Insights
The Asia Pacific region is leading the global Stem Cell Market owing to factor like; increasing investment on the research & development activities by various economies in this region, faster evolution of the stem cell sector, and few other factors.
Stem Cell Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Angel Biotechnology
- Advanced Cell Technology Inc.
- Cellartis AB
- STEMCELL Technologies Inc.
- Kite Pharma
- BIOTIME INC.
- Lonza
- Cellular Engineering Technologies Inc.
- PromoCell GmbH
- CellGenix GmbH
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Stem Cell Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Very Small Embryonic Like Stem Cells
o Adult Stem Cells
o Induced Pluripotent Stem Cells
o Human Embryonic Stem Cells
o Stem Cell Market, By Therapy, Estimates and Forecast, 2017-2027 ($Million)
o Allogeneic Stem Cell Therapy
o Autologous Stem Cell Therapy
o Stem Cell Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Drug Discovery & Development
o Regenerative Medicine
o Stem Cell Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Angel Biotechnology
o Advanced Cell Technology Inc.
o Cellartis AB
o STEMCELL Technologies Inc.
o Kite Pharma
o BIOTIME INC.
o Lonza
o Cellular Engineering Technologies Inc.
o PromoCell GmbH
o CellGenix GmbH
o Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Stem Cell Market, By Country
o U.S. Stem Cell Market
o Canada Stem Cell Market
o Mexico Stem Cell Market
o Europe
§ Europe Stem Cell Market, By Country
o Germany Stem Cell Market
o UK Stem Cell Market
o France Stem Cell Market
o Russia Stem Cell Market
o Italy Stem Cell Market
o Rest of Europe Stem Cell Market
o Asia-Pacific
§ Asia-Pacific Stem Cell Market, By Country
o China Stem Cell Market
o Japan Stem Cell Market
o South Korea Stem Cell Market
o India Stem Cell Market
o Southeast Asia Stem Cell Market
o Rest of Asia-Pacific Stem Cell Market
o South America
§ South America Stem Cell Market, By Country
o Brazil Stem Cell Market
o Argentina Stem Cell Market
o Columbia Stem Cell Market
o Rest of South America Stem Cell Market
o Middle East and Africa
§ Middle East and Africa Stem Cell Market, By Country
o Saudi Arabia Stem Cell Market
o UAE Stem Cell Market
o Egypt Stem Cell Market
o Nigeria Stem Cell Market
o South Africa Stem Cell Market
o Rest of MEA Stem Cell Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Stem Cell Market, By Product
5.1. Introduction
5.2. Global Stem Cell Revenue and Market Share by Product (2017-2027)
5.2.1. Global Stem Cell Revenue and Revenue Share by Product (2017-2027)
5.3. Very Small Embryonic Like Stem Cells
5.3.1. Global Very Small Embryonic Like Stem Cells Revenue and Growth Rate (2017-2027)
5.4. Adult Stem Cells
5.4.1. Global Adult Stem Cells Revenue and Growth Rate (2017-2027)
5.5. Induced Pluripotent Stem Cells
5.5.1. Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2027)
5.6. Human Embryonic Stem Cells
5.6.1. Global Human Embryonic Stem Cells Revenue and Growth Rate (2017-2027)
6. Stem Cell Market, By Therapy
6.1. Introduction
6.2. Global Stem Cell Revenue and Market Share by Therapy (2017-2027)
6.2.1. Global Stem Cell Revenue and Revenue Share by Therapy (2017-2027)
6.3. Allogeneic Stem Cell Therapy
6.3.1. Global Allogeneic Stem Cell Therapy Revenue and Growth Rate (2017-2027)
6.4. Autologous Stem Cell Therapy
6.4.1. Global Autologous Stem Cell Therapy Revenue and Growth Rate (2017-2027)
7. Stem Cell Market, By Application
7.1. Introduction
7.2. Global Stem Cell Revenue and Market Share by Application (2017-2027)
7.2.1. Global Stem Cell Revenue and Revenue Share by Application (2017-2027)
7.3. Drug Discovery & Development
7.3.1. Global Drug Discovery & Development Revenue and Growth Rate (2017-2027)
7.4. Regenerative Medicine
7.4.1. Global Regenerative Medicine Revenue and Growth Rate (2017-2027)
8. Stem Cell Market, By Region
8.1. Introduction
8.2. Global Stem Cell Revenue and Market Share by Regions
8.2.1. Global Stem Cell Revenue by Regions (2017-2027)
8.3. North America Stem Cell by Countries
8.3.1. North America Stem Cell Revenue and Growth Rate (2017-2027)
8.3.2. North America Stem Cell Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Stem Cell by Countries
8.4.1. Europe Stem Cell Revenue and Growth Rate (2017-2027)
8.4.2. Europe Stem Cell Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Stem Cell by Countries
8.5.1. Asia-Pacific Stem Cell Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Stem Cell Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Stem Cell by Countries
8.6.1. South America Stem Cell Revenue and Growth Rate (2017-2027)
8.6.2. South America Stem Cell Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Stem Cell by Countries
8.7.1. Middle East and Africa Stem Cell Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Stem Cell Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Angel Biotechnology
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Advanced Cell Technology Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Cellartis AB
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. STEMCELL Technologies Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Kite Pharma
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. BIOTIME INC.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Lonza
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Cellular Engineering Technologies Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. PromoCell GmbH
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. CellGenix GmbH
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Stem Cell Market Competition, by Manufacturer
10.1. Global Stem Cell Financial Overview by Manufacturer (2017-2017)
10.2. Global Stem Cell Price By Region (2017-2017)
10.3. Top 5 Stem Cell Manufacturer Market Share
10.4. Market Competition Trend
11. Stem Cell Market Forecast (2017-2027)
11.1. Global Stem Cell Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Stem Cell Market Forecast by Regions (2017-2027)
11.2.1. North America Stem Cell Market Forecast (2017-2027)
11.2.1.1. United States Stem Cell Market Forecast (2017-2027)
11.2.1.2. Canada Stem Cell Market Forecast (2017-2027)
11.2.1.3. Mexico Stem Cell Market Forecast (2017-2027)
11.2.2. Europe Stem Cell Market Forecast (2017-2027)
11.2.2.1. Germany Stem Cell Market Forecast (2017-2027)
11.2.2.2. France Stem Cell Market Forecast (2017-2027)
11.2.2.3. UK Stem Cell Market Forecast (2017-2027)
11.2.2.4. Russia Stem Cell Market Forecast (2017-2027)
11.2.2.5. Italy Stem Cell Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Stem Cell Market Forecast (2017-2027)
11.2.3. Asia-Pacific Stem Cell Market Forecast (2017-2027)
11.2.3.1. China Stem Cell Market Forecast (2017-2027)
11.2.3.2. Japan Stem Cell Market Forecast (2017-2027)
11.2.3.3. Korea Stem Cell Market Forecast (2017-2027)
11.2.3.4. India Stem Cell Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Stem Cell Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Stem Cell Market Forecast (2017-2027)
11.2.4. South America Stem Cell Market Forecast (2017-2027)
11.2.4.1. Brazil Stem Cell Market Forecast (2017-2027)
11.2.4.2. Argentina Stem Cell Market Forecast (2017-2027)
11.2.4.3. Columbia Stem Cell Market Forecast (2017-2027)
11.2.4.4. Rest of South America Stem Cell Market Forecast (2017-2027)
11.2.5. Middle East and Africa Stem Cell Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Stem Cell Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Stem Cell Market Forecast (2017-2027)
11.2.5.3. Egypt Stem Cell Market Forecast (2017-2027)
11.2.5.4. Nigeria Stem Cell Market Forecast (2017-2027)
11.2.5.5. South Africa Stem Cell Market Forecast (2017-2027)
11.2.5.6. Turkey Stem Cell Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Stem Cell Market Forecast (2017-2027)
11.3. Stem Cell Market Forecast by Product (2017-2027)
11.3.1. Stem Cell Forecast by Product (2017-2027)
11.3.2. Stem Cell Market Share Forecast by Product (2017-2027)
11.4. Stem Cell Market Forecast by Therapy (2017-2027)
11.4.1. Stem Cell Forecast by Therapy (2017-2027)
11.4.2. Stem Cell Market Share Forecast by Therapy (2017-2027)
11.5. Stem Cell Market Forecast by Application (2017-2027)
11.5.1. Stem Cell Forecast by Application (2017-2027)
11.5.2. Stem Cell Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Stem Cell Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Stem Cell Revenue and Revenue Share by Product (2017-2018)
Figure Global Very Small Embryonic Like Stem Cells Revenue and Growth Rate (2017-2018)
Figure Global Adult Stem Cells Revenue and Growth Rate (2017-2018)
Figure Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2018)
Figure Global Human Embryonic Stem Cells Revenue and Growth Rate (2017-2018)
Table Global Stem Cell Revenue and Revenue Share by Therapy (2017-2018)
Figure Global Allogeneic Stem Cell Therapy Revenue and Growth Rate (2017-2018)
Figure Global Autologous Stem Cell Therapy Revenue and Growth Rate (2017-2018)
Table Global Stem Cell Revenue and Revenue Share by Application (2017-2018)
Figure Global Drug Discovery & Development Revenue and Growth Rate (2017-2018)
Figure Global Regenerative Medicine Revenue and Growth Rate (2017-2018)
Table Global Stem Cell Revenue by Regions (2017-2018)
Figure North America Stem Cell Growth Rate (2017-2018)
Figure North America Stem Cell Revenue and Growth Rate (2017-2018)
Figure North America Stem Cell by Countries (2017-2018)
Figure North America Stem Cell Revenue (Million USD) by Countries (2017-2018)
Figure United States Stem Cell Growth Rate (2017-2018)
Figure United States Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Stem Cell Growth Rate (2017-2018)
Figure Canada Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Stem Cell Growth Rate (2017-2018)
Figure Mexico Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Stem Cell Growth Rate (2017-2018)
Figure Europe Stem Cell Revenue and Growth Rate (2017-2018)
Figure Europe Stem Cell by Countries (2017-2018)
Figure Europe Stem Cell Revenue (Million USD) by Countries (2017-2018)
Figure Germany Stem Cell Growth Rate (2017-2018)
Figure Germany Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Stem Cell Growth Rate (2017-2018)
Figure France Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Stem Cell Growth Rate (2017-2018)
Figure UK Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Stem Cell Growth Rate (2017-2018)
Figure Russia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Stem Cell Growth Rate (2017-2018)
Figure Italy Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Stem Cell Growth Rate (2017-2018)
Figure Rest of Europe Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Stem Cell Growth Rate (2017-2018)
Figure Asia-Pacific Stem Cell Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Stem Cell by Countries (2017-2018)
Figure Asia-Pacific Stem Cell Revenue (Million USD) by Countries (2017-2018)
Figure China Stem Cell Growth Rate (2017-2018)
Figure China Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Stem Cell Growth Rate (2017-2018)
Figure Japan Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Stem Cell Growth Rate (2017-2018)
Figure Korea Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Stem Cell Growth Rate (2017-2018)
Figure India Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Stem Cell Growth Rate (2017-2018)
Figure Southeast Asia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Stem Cell Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Stem Cell Growth Rate (2017-2018)
Figure South America Stem Cell Revenue and Growth Rate (2017-2018)
Figure South America Stem Cell by Countries (2017-2018)
Figure South America Stem Cell Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Stem Cell Growth Rate (2017-2018)
Figure Brazil Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Stem Cell Growth Rate (2017-2018)
Figure Argentina Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Stem Cell Growth Rate (2017-2018)
Figure Columbia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Stem Cell Growth Rate (2017-2018)
Figure Rest of South America Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Stem Cell Growth Rate (2017-2018)
Figure Middle East and Africa Stem Cell Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Stem Cell by Countries (2017-2018)
Figure Middle East and Africa Stem Cell Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Stem Cell Growth Rate (2017-2018)
Figure Saudi Arabia Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Stem Cell Growth Rate (2017-2018)
Figure United Arab Emirates Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Stem Cell Growth Rate (2017-2018)
Figure Egypt Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Stem Cell Growth Rate (2017-2018)
Figure Nigeria Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Stem Cell Growth Rate (2017-2018)
Figure South Africa Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Stem Cell Growth Rate (2017-2018)
Figure Turkey Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Stem Cell Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Stem Cell Revenue (Millions USD) and Growth Rate (2017-2018)
Table Angel Biotechnology Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Advanced Cell Technology Inc. Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cellartis AB Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table STEMCELL Technologies Inc. Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Kite Pharma Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BIOTIME INC. Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lonza Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cellular Engineering Technologies Inc. Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PromoCell GmbH Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CellGenix GmbH Stem Cell Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Stem Cell Market Share by Manufacturer
Figure Global Stem Cell Revenue and Market Share by Manufacturer
Table Global Stem Cell Price by Region (2017-2017)
Figure Top 5 Stem Cell Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Stem Cell Revenue (Millions USD) and Growth Rate (2018-2025)
Table Stem Cell Market Forecast by Regions (2018-2025)
Figure North America Stem Cell Market Forecast (2018-2025)
Figure United States Stem Cell Market Forecast (2018-2025)
Figure Canada Stem Cell Market Forecast (2018-2025)
Figure Mexico Stem Cell Market Forecast (2018-2025)
Figure Europe Stem Cell Market Forecast (2018-2025)
Figure Germany Stem Cell Market Forecast (2018-2025)
Figure France Stem Cell Market Forecast (2018-2025)
Figure UK Stem Cell Market Forecast (2018-2025)
Figure Russia Stem Cell Market Forecast (2018-2025)
Figure Italy Stem Cell Market Forecast (2018-2025)
Figure Rest of Europe Stem Cell Market Forecast (2018-2025)
Figure Asia-Pacific Stem Cell Market Forecast (2018-2025)
Figure China Stem Cell Market Forecast (2018-2025)
Figure Japan Stem Cell Market Forecast (2018-2025)
Figure Korea Stem Cell Market Forecast (2018-2025)
Figure India Stem Cell Market Forecast (2018-2025)
Figure Southeast Asia Stem Cell Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Stem Cell Market Forecast (2018-2025)
Figure South America Stem Cell Market Forecast (2018-2025)
Figure Brazil Stem Cell Market Forecast (2018-2025)
Figure Argentina Stem Cell Market Forecast (2018-2025)
Figure Columbia Stem Cell Market Forecast (2018-2025)
Figure Rest of South America Stem Cell Market Forecast (2018-2025)
Figure Middle East and Africa Stem Cell Market Forecast (2018-2025)
Figure Saudi Arabia Stem Cell Market Forecast (2018-2025)
Figure United Arab Emirates Stem Cell Market Forecast (2018-2025)
Figure Egypt Stem Cell Market Forecast (2018-2025)
Figure Nigeria Stem Cell Market Forecast (2018-2025)
Figure South Africa Stem Cell Market Forecast (2018-2025)
Figure Turkey Stem Cell Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Stem Cell Market Forecast (2018-2025)
Figure Global Stem Cell Forecast by Product (2018-2025)
Figure Global Stem Cell Market Share Forecast by Product (2018-2025)
Figure Global Stem Cell Forecast by Product (2018-2025)
Figure Global Stem Cell Forecast by Therapy (2018-2025)
Figure Global Stem Cell Market Share Forecast by Therapy (2018-2025)
Figure Global Stem Cell Forecast by Therapy (2018-2025)
Figure Global Stem Cell Forecast by Application (2018-2025)
Figure Global Stem Cell Market Share Forecast by Application (2018-2025)
Figure Global Stem Cell Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|